Barbara Diehl is a proven expert in entrepreneurship, innovation and education. In Oxford, she led early-stage investment programs and an executive education program for fast-growing small businesses. Following her return to Germany, she served as Director of Transfer and Innovation at the Helmholtz Association of German Research Centres, and now works at SPRIN-D, the German Federal Agency for Breakthrough Innovation.
Peter Mumford is a UK and European patent attorney specialising in chemical inventions, particularly small molecule therapeutics, pharmaceutical formulations, and new medical uses. He works with a broad range of clients, with considerable experience of helping spin-off and start-up life science companies to prepare for fundraising as well as due diligence for investors.
Julia Wagner is an investor at Positron Ventures, focusing on early-stage deep tech start-ups across Europe. She is passionate about turning breakthrough science into scalable companies, holds a PhD from ETH Zurich, and previously built a student-led venture fund investing in university spin-offs.
Online via MS Teams | Please register HERE!
Registration to the webinar is required in advance. Please note that you will receive the MS Teams link and access code the evening before the lecture and that access to last minute registrations, cannot be guaranteed. By participating in this webinar, you consent to the sharing of your email address with our SPARK Partners for the sole purpose of providing information and resources related to their certification programs. Your information will not be used for any other purpose without your explicit consent.
SPARK Europe is the joint network of SPARK sites all over Europe including Israel: SPARK-BIH, SPARK Finland, SPARK FLI, SPARK Norway, SPARK Poland, SPARK Tel Aviv, SPARK Denmark, SPARK Zürich and SPARK at the Faculty of Medicine, Masaryk University. European SPARK programs are members of SPARK Global network. The purpose of SPARK programs is to provide the education and mentorship necessary to advance research discoveries from the bench to the bedside, hence to increase the maturity of academic and clinical discoveries towards practical solutions that address unmet needs in the life science and health tech space. The program follows the same principles that have been the cornerstones of SPARK at Stanford since it was established by Professor Daria Mochly-Rosen and Kevin Grimes in 2006 for advancing new biomedical research discoveries into promising new treatments for patients.
